Oregon State University researchers have discovered a way to get anti-inflammatory medicine across the blood-brain barrier, opening the door to potential new therapies for a range of conditions, including Alzheimer’s disease, multiple sclerosis, Parkinson’s disease and cancer cachexia.
The delivery method involves specially engineered nanoparticles, tiny bits of matter no larger than 100 billionths of a meter.
Tested in a mouse model, the dual peptide-functionalized polymeric nanocarriers…
Continue Reading
News Source: www.sciencedaily.com
Leave a Reply